As the COVID-19 respiratory virus spreads around the world, the International Myeloma Foundation (IMF) continues to be here for you. The IMF takes the health and safety of myeloma patients seriously. To contain the spread of the virus, we recommend cancelling in-person support group meetings.
The IMF has offered to support group leaders the technology and instruction to host virtual meetings using GoToMeeting. Please contact your support group leader for specific details regarding your meeting.
For additional updates on COVID-19 coronavirus, please click this link:
Myeloma Patient Safety and the Coronavirus.
The East Texas Multiple Myeloma Support Group, founded in 2007, meets on the 2nd Saturday of each month from 11:00 AM - 1:00 PM at the Gardens of Gladewater, 108 Lee Street, Gladewater, TX 75647. For more information, please contact Donna LaRocque at 903-431-6291 or email: firstname.lastname@example.org
Multiple Myeloma is a tumor involving the blood producing cells in the bone marrow. A cancerous plasma cell is called a Myeloma and Myeloma is called "multiple" since there are frequently multiple areas in the bones where tumors or lesions have developed.
Myeloma cells crowd out normal blood cells and affect the immune system. A specific cause has not yet been identified.
Most patients who have multiple Myeloma don't die from the disease itself, they die from other diseases the Myeloma makes them more susceptible to.
Despite the fact there is no cure for the disease, many people who have it can be treated so they can live fairly normal lives, she said.
When Donna LaRocque's husband, Roger, was diagnosed with the disease in spring 2005, the Gladewater couple knew little about it. They felt alone in facing the unknown of treatment.
"There were other types of support groups in the East Texas area, but nothing for people who had multiple Myeloma and their families. People in other groups dealing with other types of cancer can't relate — even for leukemia there's a cure — but not for multiple Myeloma patients. It's unique."